2.06
price up icon2.45%   0.02
after-market 시간 외 거래: 1.97 -0.09 -4.37%
loading
전일 마감가:
$2.04
열려 있는:
$2.05
하루 거래량:
312.81K
Relative Volume:
2.27
시가총액:
$119.53M
수익:
-
순이익/손실:
$-46.12M
주가수익비율:
-2.7584
EPS:
-0.7468
순현금흐름:
$-41.02M
1주 성능:
+2.96%
1개월 성능:
+36.60%
6개월 성능:
+37.50%
1년 성능:
+43.15%
1일 변동 폭
Value
$1.97
$2.14
1주일 범위
Value
$1.51
$2.37
52주 변동 폭
Value
$1.165
$2.44

Inflarx N V Stock (IFRX) Company Profile

Name
명칭
Inflarx N V
Name
전화
-
Name
주소
-
Name
직원
66
Name
트위터
Name
다음 수익 날짜
2024-11-08
Name
최신 SEC 제출 서류
Name
IFRX's Discussions on Twitter

IFRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
IFRX 2.06 119.53M 0 -46.12M -41.02M -0.7468
VRTX 450.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 24.89B 3.30B -501.07M 1.03B 11.54

Inflarx N V Stock (IFRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-04-05 업그레이드 Guggenheim Neutral → Buy
2022-02-28 다운그레이드 Guggenheim Buy → Neutral
2021-10-28 업그레이드 Raymond James Outperform → Strong Buy
2021-03-11 업그레이드 Guggenheim Neutral → Buy
2020-11-06 업그레이드 SVB Leerink Mkt Perform → Outperform
2020-10-08 개시 H.C. Wainwright Buy
2020-06-17 개시 BTIG Research Buy
2020-04-30 업그레이드 Raymond James Mkt Perform → Outperform
2019-06-05 다운그레이드 BMO Capital Markets Outperform → Market Perform
2019-06-05 다운그레이드 Guggenheim Buy → Neutral
2019-06-05 다운그레이드 JP Morgan Overweight → Underweight
2019-06-05 다운그레이드 Robert W. Baird Outperform → Neutral
2019-06-05 다운그레이드 SunTrust Buy → Hold
2019-01-29 개시 Robert W. Baird Outperform
2018-12-10 개시 Credit Suisse Outperform
2018-07-13 개시 BMO Capital Markets Outperform
2018-06-28 개시 Raymond James Outperform
2018-06-28 개시 SunTrust Buy
2018-02-08 개시 B. Riley FBR, Inc. Buy
모두보기

Inflarx N V 주식(IFRX)의 최신 뉴스

pulisher
Nov 19, 2024

10 Best German Stocks To Buy Now - Insider Monkey

Nov 19, 2024
pulisher
Nov 19, 2024

Is InflaRx N.V. (IFRX) the Best German Stock to Buy Now? - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Lucid Capital sets Inflarx NV Buy stock rating on clinical trial potential - Investing.com

Nov 19, 2024
pulisher
Nov 15, 2024

InflaRx receives positive CHMP opinion for SARS-CoV-2-induced acute respiratory distress treatment - MSN

Nov 15, 2024
pulisher
Nov 15, 2024

InflaRx's GOHIBIC gets EMA panel nod for COVID-19 ARDS By Investing.com - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

InflaRx's GOHIBIC gets EMA panel nod for COVID-19 ARDS - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

InflaRx’s GOHIBIC gets EMA panel nod for COVID-19 ARDS By Investing.com - ழ தொலைக்காட்சி

Nov 15, 2024
pulisher
Nov 15, 2024

InflaRx Receives Positive CHMP Opinion for GOHIBIC® - GlobeNewswire

Nov 15, 2024
pulisher
Nov 15, 2024

InflaRx's GOHIBIC Secures Key EU Backing for COVID ARDS Treatment After 24% Mortality Reduction | IFRX Stock News - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

FY2024 EPS Estimates for InflaRx Cut by Leerink Partnrs - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

U.S. Stock market top gainers: Omeros Corporation gains 52.99% while InflaRx N.V surges by 40.94% - Business Upturn

Nov 14, 2024
pulisher
Nov 14, 2024

FY2024 Earnings Forecast for InflaRx Issued By HC Wainwright - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimates for InflaRx Reduced by Leerink Partnrs - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Prenetics Global And 2 Other US Penny Stocks To Watch - Simply Wall St

Nov 13, 2024
pulisher
Nov 12, 2024

InflaRx Reports Q3 2024 Financial Results and Progress - Yahoo Finance

Nov 12, 2024
pulisher
Nov 11, 2024

InflaRx (NASDAQ:IFRX) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

We're A Little Worried About InflaRx's (NASDAQ:IFRX) Cash Burn Rate - Yahoo Finance

Nov 10, 2024
pulisher
Nov 08, 2024

InflaRx N.V. (IFRX) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

InflaRx Reports Rising Revenue Amidst Significant Losses - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

InflaRx Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 08, 2024
pulisher
Nov 07, 2024

InflaRx (IFRX) to Release Earnings on Friday - Defense World

Nov 07, 2024
pulisher
Nov 01, 2024

InflaRx (IFRX) Set to Announce Quarterly Earnings on Friday - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

InflaRx to Report Third Quarter 2024 Financial Results on November 8 and to Participate in Guggenheim Inaugural Healthcare Innovation Conference - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

InflaRx to Report Third Quarter 2024 Financial Results on - GlobeNewswire

Oct 31, 2024
pulisher
Oct 22, 2024

Critical Review: PDS Biotechnology (NASDAQ:PDSB) & InflaRx (NASDAQ:IFRX) - Defense World

Oct 22, 2024
pulisher
Oct 14, 2024

InflaRx (NASDAQ:IFRX) Sees Significant Increase in Short Interest - MarketBeat

Oct 14, 2024
pulisher
Sep 26, 2024

InflaRx shares maintain Buy rating from H.C. Wainwright on Gohibic trial analysis - Investing.com

Sep 26, 2024
pulisher
Sep 25, 2024

InflaRx (NASDAQ:IFRX) Given Buy Rating at HC Wainwright - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx reports promising HS treatment results at EADV Congress - Investing.com India

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx (NASDAQ:IFRX) Given "Buy" Rating at HC Wainwright - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx presents e-poster presentation of post hoc analysis of SHINE study - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx Presents Post Hoc Analysis of SHINE Trial of - GlobeNewswire

Sep 25, 2024
pulisher
Sep 25, 2024

InflaRx Presents Post Hoc Analysis of SHINE Trial of Vilobelimab in Hidradenitis Suppurativa at the 2024 - EIN News

Sep 25, 2024
pulisher
Sep 05, 2024

InflaRx Announces Participation in September Investor Events - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 05, 2024

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases - Yahoo Finance UK

Sep 05, 2024
pulisher
Sep 04, 2024

InflaRx (NASDAQ:IFRX) Stock Price Up 1.3% - MarketBeat

Sep 04, 2024
pulisher
Sep 04, 2024

InflaRx (NASDAQ:IFRX) Shares Up 1.3% - Defense World

Sep 04, 2024
pulisher
Sep 03, 2024

InflaRx reports promising data on oral C5aR inhibitor INF904 - Investing.com

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human - EIN News

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx reports promising data on oral C5aR inhibitor INF904 By Investing.com - Investing.com UK

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx presents new preclinical findings for INF904 - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

InflaRx Presents New Preclinical Findings for INF904 at the - GlobeNewswire

Sep 03, 2024
pulisher
Sep 01, 2024

InflaRx (NASDAQ:IFRX) Short Interest Down 9.2% in August - MarketBeat

Sep 01, 2024
pulisher
Aug 13, 2024

Short Interest in InflaRx (NASDAQ:IFRX) Rises By 281.4% - MarketBeat

Aug 13, 2024
pulisher
Aug 08, 2024

InflaRx N.V. (IFRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Aug 08, 2024
pulisher
Aug 08, 2024

InflaRx N.V. Reports Mid-Year Financial Results - TipRanks

Aug 08, 2024
pulisher
Aug 08, 2024

InflaRx Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Aug 08, 2024
pulisher
Aug 08, 2024

InflaRx reports Q2 EPS (24c), consensus (22c) - TipRanks

Aug 08, 2024
pulisher
Aug 07, 2024

InflaRx (IFRX) Set to Announce Earnings on Thursday - Defense World

Aug 07, 2024
pulisher
Aug 02, 2024

InflaRx (IFRX) to Release Earnings on Thursday - MarketBeat

Aug 02, 2024

Inflarx N V (IFRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
자본화:     |  볼륨(24시간):